EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Therapie, 65 3 (2010) 163-169 Article's citations

Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Predictive factors for delayed high-dose methotrexate elimination: A practical issue for diffuse large B-cell lymphoma patients

Margot Vattaire-Hervé, Antoine Le Bozec, Justine Clarenne, Guillaume Cohet, Violaine Lepage, Chloé Gossery, Elise Michelet-Huot, Anne Quinquenel, Isabelle Madelaine, Eric Durot and Florian Slimano
Journal of Oncology Pharmacy Practice (2025)
https://doi.org/10.1177/10781552251340000

The interest of therapeutic and pharmacological drug monitoring of methotrexate: A systematic review

Wissal Chellal, Youssra Metarfi, Zineb Ben Khadda, Hasnae Hoummani, Rhizlane Berrady and Sanae Achour
Seminars in Oncology 52 (2) 152342 (2025)
https://doi.org/10.1016/j.seminoncol.2025.152342

Real-Time, Seconds-Resolved Measurements of Plasma Methotrexate In Situ in the Living Body

Alejandro Chamorro-Garcia, Julian Gerson, Charlotte Flatebo, Lisa Fetter, Alex M. Downs, Nicole Emmons, Herbert L. Ennis, Nenad Milosavić, Kyungae Yang, Milan Stojanovic, Francesco Ricci, Tod E. Kippin and Kevin W. Plaxco
ACS Sensors 8 (1) 150 (2023)
https://doi.org/10.1021/acssensors.2c01894

Plasma 7-Hydroxymethotrexate Levels Versus Methotrexate to Predict Delayed Elimination in Children Receiving High-Dose Methotrexate

Nicolas Fabresse, Bénédicte Devictor, Christel Pissier, et al.
Therapeutic Drug Monitoring 40 (1) 76 (2018)
https://doi.org/10.1097/FTD.0000000000000445

A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy

Régis Bouquié, Guillaume Deslandes, Blanca Nieto Bernáldez, et al.
Anal. Methods 6 (1) 178 (2014)
https://doi.org/10.1039/C3AY40815A

A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy

Régis Bouquié, Guillaume Deslandes, Blanca Nieto Bernáldez, et al.
Analytical Methods 6 (1) 178 (2014)
https://doi.org/10.1039/c3ay40815a

Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor

Sandy Shuo Zhao, Mathilde A. Bichelberger, Damien Y. Colin, et al.
The Analyst 137 (20) 4742 (2012)
https://doi.org/10.1039/c2an35839e

Evidence for Therapeutic Drug Monitoring of Targeted Anticancer Therapies

Bo Gao, Shang Yeap, Arthur Clements, Bavanthi Balakrishnar, Mark Wong and Howard Gurney
Journal of Clinical Oncology 30 (32) 4017 (2012)
https://doi.org/10.1200/JCO.2012.43.5362

Suivi thérapeutique pharmacologique du méthotrexate à faible dose dans les maladies inflammatoires

Marie-Clémence Verdier, Olivier Tribut, Sophie Bodeau, Dorothée Rihouey and Danièle Bentué-Ferrer
Thérapie 66 (1) 63 (2011)
https://doi.org/10.2515/therapie/2011002